Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
To investigate the use of self-administered artesunate vaginal pessaries as treatment for
cervical precancer in low and middle-income countries (LMIC). The central hypothesis of this
study is that self-administered intravaginal Artesunate will be safe, and result in a
clinical response among both HIV-positive and HIV-negative women with cervical precancer in
LMICs.